Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Total Non-Current Liabilities (2021)

Actinium Pharmaceuticals (ATNM) has disclosed Total Non-Current Liabilities for 1 consecutive years, with $5.8 million as the latest value for Q4 2021.

  • Quarterly Total Non-Current Liabilities changed N/A to $5.8 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Dec 2021, changed N/A year-over-year, with the annual reading at $5.8 million for FY2021, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was $5.8 million at Actinium Pharmaceuticals.
  • The five-year high for Total Non-Current Liabilities was $5.8 million in Q4 2021, with the low at $5.8 million in Q4 2021.